Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-03-07 @ 11:47 PM
Study NCT ID:
NCT03450850
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-16
First Post:
2018-01-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma
Sponsor:
Daniela A. Bota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-23
First Submit QC Date:
None
Study First Post Date:
2018-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-30
Results First Submit QC Date:
None
Results First Post Date:
2025-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-16
Last Update Post Date Type:
ACTUAL